Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    BeOne Medicines Ltd.

    NASDAQ: ONC · Real-Time Price · USD
    264.41
    -5.22 (-1.94%)
    At close: Jun 16, 2025, 3:59 PM
    265.01
    0.23%
    After-hours: Jun 16, 2025, 07:27 PM EDT

    BeOne Medicines Statistics

    Share Statistics

    BeOne Medicines has 99.37M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 99.37M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 4,931

    FTD / Avg. Volume

    n/a
    		 1.1%

    Short Selling Information

    The latest short interest is 2.03M, so 1.88% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.03M

    Short % of Shares Out

    n/a
    		 1.88%

    Short % of Float

    n/a
    		 2.69%

    Short Ratio (days to cover)

    n/a
    		 7.59

    Valuation Ratios

    The PE ratio is -30.16 and the forward PE ratio is 40.34. BeOne Medicines's PEG ratio is 1.09.

    PE Ratio

    n/a
    		 -30.16

    Forward PE

    n/a
    		 40.34

    PS Ratio

    n/a
    		 5.1

    Forward PS

    n/a
    		 4.3

    PB Ratio

    n/a
    		 5.84

    P/FCF Ratio

    n/a
    		 -29.04

    PEG Ratio

    n/a
    		 1.09
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for BeOne Medicines.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.8, with a Debt / Equity ratio of 0.32.

    Current Ratio

    n/a
    		 1.8

    Quick Ratio

    n/a
    		 1.58

    Debt / Equity

    n/a
    		 0.32

    Debt / EBITDA

    n/a
    		 -2.72

    Debt / FCF

    n/a
    		 -1.61

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $346,385.55

    Profits Per Employee

    n/a
    		 $-58,616.91

    Employee Count

    n/a
    		 11,000

    Asset Turnover

    n/a
    		 0.64

    Inventory Turnover

    n/a
    		 1.2

    Taxes

    Income Tax

    n/a
    		 111.78M

    Effective Tax Rate

    n/a
    		 -20.97%

    Stock Price Statistics

    The stock price has increased by 65.9% in the last 52 weeks. The beta is 0.29, so BeOne Medicines's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.29

    52-Week Price Change

    n/a
    		 65.9%

    50-Day Moving Average

    n/a
    		 242.24

    200-Day Moving Average

    n/a
    		 223.18

    Relative Strength Index (RSI)

    n/a
    		 59.86

    Average Volume (20 Days)

    n/a
    		 446,260

    Income Statement

    In the last 12 months, BeOne Medicines had revenue of 3.81B and earned -644.79M in profits. Earnings per share was -6.12.

    Revenue

    n/a
    		 3.81B

    Gross Profit

    n/a
    		 3.22B

    Operating Income

    n/a
    		 -568.2M

    Net Income

    n/a
    		 -644.79M

    EBITDA

    n/a
    		 -396.44M

    EBIT

    n/a
    		 -568.2M

    Earnings Per Share (EPS)

    n/a
    		 -6.12
    Full Income Statement

    Balance Sheet

    The company has 2.63B in cash and 1.08B in debt, giving a net cash position of 1.55B.

    Cash & Cash Equivalents

    n/a
    		 2.63B

    Total Debt

    n/a
    		 1.08B

    Net Cash

    n/a
    		 1.55B

    Retained Earnings

    n/a
    		 -8.61B

    Total Assets

    n/a
    		 5.84B

    Working Capital

    n/a
    		 1.91B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -140.63M and capital expenditures -529.14M, giving a free cash flow of -669.77M.

    Operating Cash Flow

    n/a
    		 -140.63M

    Capital Expenditures

    n/a
    		 -529.14M

    Free Cash Flow

    n/a
    		 -669.77M

    FCF Per Share

    n/a
    		 -0.49
    Full Cash Flow Statement

    Margins

    Gross margin is 84.41%, with operating and profit margins of -14.91% and -16.92%.

    Gross Margin

    n/a
    		 84.41%

    Operating Margin

    n/a
    		 -14.91%

    Pretax Margin

    n/a
    		 -13.99%

    Profit Margin

    n/a
    		 -16.92%

    EBITDA Margin

    n/a
    		 -10.4%

    EBIT Margin

    n/a
    		 -14.91%

    FCF Margin

    n/a
    		 -17.58%

    Dividends & Yields

    ONC does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ONC is $325.5, which is 23.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $325.5

    Price Target Difference

    n/a
    		 23.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 5.59

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist